+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Continuous Manufacturing For Small Molecule APIs Market Size, Share & Trends Analysis Report by Equipment (Reactors, Crystallizers, Filtration Systems), Unit Operation, Type, End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 120 Pages
  • October 2024
  • Region: Global
  • Grand View Research
  • ID: 6024571
Description Jump to:
The global continuous manufacturing for small molecule APIs market size is anticipated to reach USD 671.52 million by 2030, growing at a CAGR of 10.42% from 2024 to 2030. This robust expansion can be attributed to several key drivers that reflect current industry trends, advancements in technology, and changing regulatory landscapes. Continuous manufacturing processes offer significant advantages over traditional batch processing, including increased efficiency, reduced production costs, and improved product quality. The United States Food and Drug Administration (FDA) has actively promoted continuous manufacturing technologies, recognizing their potential to streamline the drug production process and enhance the overall quality of pharmaceutical products. For instance, the FDA’s “Pharmaceutical Quality for the 21st Century” initiative highlights continuous manufacturing as a key focus area, encouraging companies to adopt these innovative approaches to ensure better control over production variables.

Recent technological advancements further propel the continuous manufacturing market. Innovations in process analytical technology (PAT) enable real-time monitoring of production processes, ensuring consistent quality and compliance with regulatory standards. For instance, in July 2024, GEA introduced new continuous processing technologies designed to enhance flexibility and efficiency in pharmaceutical manufacturing. At ACHEMA 2024, GEA showcased its collaboration with Hovione, emphasizing the ConsiGma CDC flex system. This system supports both continuous and batch processes with varied throughput, improving production quality and sustainability. Their partnership aims to simplify operations and make continuous manufacturing more accessible across the industry.These technologies not only increase efficiency but also significantly shorten time-to-market for new drugs, an essential factor in an increasingly competitive pharmaceutical industry.

Government initiatives and support also play a crucial role in the growth of the continuous manufacturing market. Various countries are recognizing the need for modernization in pharmaceutical manufacturing to enhance competitiveness and improve public health outcomes. For example, the U.S. government has introduced programs aimed at facilitating the adoption of continuous manufacturing technologies, providing funding and resources to support innovation within the industry. Similarly, the European Medicines Agency (EMA) has been encouraging the use of continuous processes, promoting guidelines that facilitate the implementation of these technologies within Europe’s pharmaceutical sector.

Continuous Manufacturing For Small Molecule APIs Market Report Highlights

  • Based on equipment, reactors dominated the market with a substantial share of 35.2% in 2023 and are expected to grow at the fastest CAGR of 11.0% during the forecast period
  • Based on unit operation, the synthesis segment held the largest revenue share of 39.1% in 2023 driven by technological advancements, efficiency gains, and a shift toward sustainable practices, positioning it for continued expansion in the coming years
  • Based on type, generic APIs dominated the market, capturing a substantial revenue share of 10.8% in 2023
  • Based on end use, CMO/CDMOs dominated the market, capturing a substantial revenue share of 70.2% in 2023

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
  • Competitive Landscape: Explore the market presence of key players worldwide
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

The leading players in the Continuous Manufacturing For Small Molecule APIs market include:

  • Pfizer Inc.
  • GSK plc. (GlaxoSmithKline)
  • Vertex Pharmaceuticals Incorporated
  • Janssen (a subsidiary of Johnson & Johnson)
  • Abbvie Inc.
  • Sterling Pharma Solutions
  • Evonik Industries AG
  • Cambrex Corporation
  • Patheon (part of Thermo Fisher Scientific)
  • Hovione
  • Lonza
  • Phlow
  • Asymchem
  • GEA Group AG
  • Thermo Fisher Scientific
  • Corning Incorporated
  • Coperion GmbH
  • Continuus Pharmaceuticals
  • Chemtrix
  • Vapourtec Ltd
  • Ehrfeld Mikrotechnik GmbH
  • NiTech Solutions Ltd

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Equipment
1.2.2. Unit Operation
1.2.3. Type
1.2.4. End Use
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Equipment Outlook
2.2.2. Unit Operation
2.2.3. Type
2.2.4. End Use
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Continuous Manufacturing for Small Molecule APIs Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rapid growth in the global pharmaceutical industry
3.2.1.2. Growing role of flow chemistry in API manufacturing
3.2.1.3. Growing adoption and improved efficiency & productivity
3.2.1.4. Emergence as a green, sustainable and profitable process technology
3.2.2. Market restraint analysis
3.2.2.1. High R&D investment and capital cost
3.2.2.2. Regulatory compliance and process validation
3.3. Continuous Manufacturing for Small Molecule APIs Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Continuous Manufacturing for Small Molecule APIs Market: Equipment Estimates & Trend Analysis
4.1. Global Continuous Manufacturing for Small Molecule APIs Market: Equipment Dashboard
4.2. Global Continuous Manufacturing for Small Molecule APIs Market: Equipment Movement Analysis
4.3. Global Continuous Manufacturing for Small Molecule APIs Market by Equipment, Revenue
4.4. Reactors
4.4.1. Reactors market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Crystallizers
4.5.1. Crystallizers market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Filtration Systems
4.6.1. Filtration Systems market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Mixers
4.7.1. Mixers market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Heat Exchangers
4.8.1. Heat Exchangers market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Others (Dryers, etc.)
4.9.1. Others (Dryers, etc.) market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Estimates & Trend Analysis
5.1. Global Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Dashboard
5.2. Global Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Movement Analysis
5.3. Global Continuous Manufacturing for Small Molecule APIs Market Estimates and Forecasts, By Unit Operation, Revenue (USD Million)
5.4. Synthesis
5.4.1. Synthesis market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Separation & Purification
5.5.1. Separation & Purification market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Drying
5.6.1. Drying market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Continuous Manufacturing for Small Molecule APIs Market: Type Estimates & Trend Analysis
6.1. Global Continuous Manufacturing for Small Molecule APIs Market: Type Dashboard
6.2. Global Continuous Manufacturing for Small Molecule APIs Market: Type Movement Analysis
6.3. Global Continuous Manufacturing for Small Molecule APIs Market Estimates and Forecasts, By Type, Revenue (USD Million)
6.4. Generic APIs
6.4.1. Generic APIs market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Innovative APIs
6.5.1. Innovative APIs market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Continuous Manufacturing for Small Molecule APIs Market: End Use Estimates & Trend Analysis
7.1. Global Continuous Manufacturing for Small Molecule APIs Market: End Use Dashboard
7.2. Global Continuous Manufacturing for Small Molecule APIs Market: End Use Movement Analysis
7.3. Global Continuous Manufacturing for Small Molecule APIs Market Estimates and Forecasts, By End Use, Revenue (USD Million)
7.4. CMOs/CDMOs
7.4.1. CMOs/CDMOs market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Pharmaceutical Companies
7.5.1. Pharmaceutical Companies market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Academic & Research Institutes
7.6.1. Academic & Research Institutes market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Continuous Manufacturing for Small Molecule APIs Market: Regional Estimates & Trend Analysis by Equipment, Unit Operation, Type and End Use
8.1. Regional Dashboard
8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.3. North America
8.3.1. U.S.
8.3.1.1. Key country dynamics
8.3.1.2. Regulatory framework/ reimbursement structure
8.3.1.3. Competitive scenario
8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.3.2. Canada
8.3.2.1. Key country dynamics
8.3.2.2. Regulatory framework/ reimbursement structure
8.3.2.3. Competitive scenario
8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.3.3. Mexico
8.3.3.1. Key country dynamics
8.3.3.2. Regulatory framework/ reimbursement structure
8.3.3.3. Competitive scenario
8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.4.2. Germany
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.4.3. France
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.4.4. Italy
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework/ reimbursement structure
8.4.4.3. Competitive scenario
8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.4.5. Spain
8.4.5.1. Key country dynamics
8.4.5.2. Regulatory framework/ reimbursement structure
8.4.5.3. Competitive scenario
8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.4.6. Norway
8.4.6.1. Key country dynamics
8.4.6.2. Regulatory framework/ reimbursement structure
8.4.6.3. Competitive scenario
8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.4.7. Sweden
8.4.7.1. Key country dynamics
8.4.7.2. Regulatory framework/ reimbursement structure
8.4.7.3. Competitive scenario
8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.4.8. Denmark
8.4.8.1. Key country dynamics
8.4.8.2. Regulatory framework/ reimbursement structure
8.4.8.3. Competitive scenario
8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. China
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. India
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.5.4. Australia
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.5.5. South Korea
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.5.6. Thailand
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Argentina
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. UAE
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. Kuwait
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Vendor Landscape
9.2.1. List of key distributors and channel partners
9.2.2. Key company market share analysis, 2023
9.2.3. Pfizer Inc
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Equipment benchmarking
9.2.3.4. Strategic initiatives
9.2.4. GSK plc. (GlaxoSmithKline)
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Equipment benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Vertex Pharmaceuticals Incorporated
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Equipment benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Janssen (a subsidiary of Johnson & Johnson)
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Equipment benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Abbvie Inc.
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Equipment benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Sterling Pharma Solutions
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Equipment benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Evonik Industries AG
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Equipment benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Cambrex Corporation
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Equipment benchmarking
9.2.10.4. Strategic initiatives
9.2.11. Patheon
9.2.11.1. Company overview
9.2.11.2. Financial performance
9.2.11.3. Equipment benchmarking
9.2.11.4. Strategic initiatives
9.2.12. Hovione
9.2.12.1. Company overview
9.2.12.2. Financial performance
9.2.12.3. Equipment benchmarking
9.2.12.4. Strategic initiatives
9.2.13. Lonza
9.2.13.1. Company overview
9.2.13.2. Financial performance
9.2.13.3. Equipment benchmarking
9.2.13.4. Strategic initiatives
9.2.14. Phlow
9.2.14.1. Company overview
9.2.14.2. Financial performance
9.2.14.3. Equipment benchmarking
9.2.14.4. Strategic initiatives
9.2.15. Asymchem
9.2.15.1. Company overview
9.2.15.2. Financial performance
9.2.15.3. Equipment benchmarking
9.2.15.4. Strategic initiatives
9.2.16. GEA Group AG
9.2.16.1. Company overview
9.2.16.2. Financial performance
9.2.16.3. Equipment benchmarking
9.2.16.4. Strategic initiatives
9.2.17. Thermo Fisher Scientific
9.2.17.1. Company overview
9.2.17.2. Financial performance
9.2.17.3. Equipment benchmarking
9.2.17.4. Strategic initiatives
9.2.18. Corning Incorporated
9.2.18.1. Company overview
9.2.18.2. Financial performance
9.2.18.3. Equipment benchmarking
9.2.18.4. Strategic initiatives
9.2.19. Coperion GmbH
9.2.19.1. Company overview
9.2.19.2. Financial performance
9.2.19.3. Equipment benchmarking
9.2.19.4. Strategic initiatives
9.2.20. Continuus Pharmaceuticals
9.2.20.1. Company overview
9.2.20.2. Financial performance
9.2.20.3. Equipment benchmarking
9.2.20.4. Strategic initiatives
9.2.21. Chemtrix
9.2.21.1. Company overview
9.2.21.2. Financial performance
9.2.21.3. Equipment benchmarking
9.2.21.4. Strategic initiatives
9.2.22. Vapourtec Ltd
9.2.22.1. Company overview
9.2.22.2. Financial performance
9.2.22.3. Equipment benchmarking
9.2.22.4. Strategic initiatives
9.2.23. Ehrfeld Mikrotechnik GmbH
9.2.23.1. Company overview
9.2.23.2. Financial performance
9.2.23.3. Equipment benchmarking
9.2.23.4. Strategic initiatives
9.2.24. NiTech Solutions Ltd
9.2.24.1. Company overview
9.2.24.2. Financial performance
9.2.24.3. Equipment benchmarking
9.2.24.4. Strategic initiatives
List of Tables
Table 1 List Of Abbreviation
Table 2 North America Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
Table 3 North America Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 4 North America Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 5 North America Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 6 North America Continuous Manufacturing for Small Molecule APIs Market, End Use, 2018 - 2030 (USD Million)
Table 7 U.S. Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 8 U.S. Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 9 U.S. Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 10 U.S. Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 11 Canada Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 12 Canada Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 13 Canada Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 14 Canada Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 15 Mexico Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 16 Mexico Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 17 Mexico Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 18 Mexico Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 19 Europe Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
Table 20 Europe Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 21 Europe Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 22 Europe Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 23 Europe Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 24 Germany Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 25 Germany Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 26 Germany Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 27 Germany Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 28 UK Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 29 UK Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 30 UK Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 31 UK Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 32 France Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 33 France Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 34 France Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 35 France Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 36 Italy Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 37 Italy Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 38 Italy Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 39 Italy Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 40 Spain Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 41 Spain Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 42 Spain Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 43 Spain Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 44 Denmark Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 45 Denmark Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 46 Denmark Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 47 Denmark Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 48 Sweden Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 49 Sweden Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 50 Sweden Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 51 Sweden Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 52 Norway Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 53 Norway Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 54 Norway Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 55 Norway Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 56 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
Table 57 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 61 China Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 62 China Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 63 China Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 64 China Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 65 Japan Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 66 Japan Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 67 Japan Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 68 Japan Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 69 India Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 70 India Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 71 India Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 72 India Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 73 South Korea Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 74 South Korea Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 75 South Korea Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 76 South Korea Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 77 Australia Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 78 Australia Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 79 Australia Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 80 Australia Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 81 Thailand Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 82 Thailand Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 83 Thailand Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 84 Thailand Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 85 Latin America Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
Table 86 Latin America Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 87 Latin America Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 88 Latin America Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 89 Latin America Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 90 Brazil Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 91 Brazil Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 92 Brazil Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 93 Brazil Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 94 Argentina Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 95 Argentina Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 96 Argentina Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 97 Argentina Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 98 MEA Continuous Manufacturing for Small Molecule APIs Market, By Region, 2018 - 2030 (USD Million)
Table 99 MEA Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 100 MEA Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 101 MEA Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 102 MEA Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 103 South Africa Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 104 South Africa Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 105 South Africa Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 106 South Africa Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 111 UAE Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 112 UAE Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 113 UAE Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 114 UAE Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
Table 115 Kuwait Continuous Manufacturing for Small Molecule APIs Market, By Equipment, 2018 - 2030 (USD Million)
Table 116 Kuwait Continuous Manufacturing for Small Molecule APIs Market, By Unit Operation, 2018 - 2030 (USD Million)
Table 117 Kuwait Continuous Manufacturing for Small Molecule APIs Market, By Type, 2018 - 2030 (USD Million)
Table 118 Kuwait Continuous Manufacturing for Small Molecule APIs Market, By End Use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Continuous Manufacturing for Small Molecule APIs Market: Market Outlook
Fig. 14 Colorectal Surgery Competitive Insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Continuous Manufacturing for Small Molecule APIs Market Driver Impact
Fig. 18 Continuous Manufacturing for Small Molecule APIs Market Restraint Impact
Fig. 19 Continuous Manufacturing for Small Molecule APIs Market Strategic Initiatives Analysis
Fig. 20 Continuous Manufacturing for Small Molecule APIs Market: Equipment Movement Analysis
Fig. 21 Continuous Manufacturing for Small Molecule APIs Market: Equipment Outlook And Key Takeaways
Fig. 22 Reactors market estimates and forecast, 2018 - 2030
Fig. 23 Crystallizers market estimates and forecast, 2018 - 2030
Fig. 24 Filtration Systems market estimates and forecast, 2018 - 2030
Fig. 25 Mixers market estimates and forecast, 2018 - 2030
Fig. 26 Heat Exchangers market estimates and forecast, 2018 - 2030
Fig. 27 Others (Dryers, etc.) market estimates and forecast, 2018 - 2030
Fig. 28 Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Movement Analysis
Fig. 29 Continuous Manufacturing for Small Molecule APIs Market: Unit Operation Outlook And Key Takeaways
Fig. 30 Synthesis market estimates and forecast, 2018 - 2030
Fig. 31 Separation & Purification Separation & Purification market estimates and forecast, 2018 - 2030
Fig. 32 Continuous Manufacturing for Small Molecule APIs Market: Type Movement Analysis
Fig. 33 Continuous Manufacturing for Small Molecule APIs Market: Type Outlook And Key Takeaways
Fig. 34 Generic APIs market estimates and forecast, 2018 - 2030
Fig. 35 Innovative APIs market estimates and forecast, 2018 - 2030
Fig. 36 Continuous Manufacturing for Small Molecule APIs Market: End Use Movement Analysis
Fig. 37 Continuous Manufacturing for Small Molecule APIs Market: End Use Outlook And Key Takeaways
Fig. 38 CMOs/CDMOs market estimates and forecast, 2018 - 2030
Fig. 39 Pharmaceutical Companies market estimates and forecast, 2018 - 2030
Fig. 40 Academic & Research Institutes market estimates and forecast, 2018 - 2030
Fig. 41 Global Continuous Manufacturing for Small Molecule APIs Market: Regional Movement Analysis
Fig. 42 Global Continuous Manufacturing for Small Molecule APIs Market: Regional Outlook And Key Takeaways
Fig. 43 Global Continuous Manufacturing for Small Molecule APIs Market share and leading players
Fig. 44 North America, by country
Fig. 45 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 U.S. key country dynamics
Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Canada key country dynamics
Fig. 49 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Mexico key country dynamics
Fig. 51 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 UK key country dynamics
Fig. 54 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Germany key country dynamics
Fig. 56 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 France key country dynamics
Fig. 58 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Italy key country dynamics
Fig. 60 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Spain key country dynamics
Fig. 62 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Denmark key country dynamics
Fig. 64 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Sweden key country dynamics
Fig. 66 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Norway key country dynamics
Fig. 68 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 China key country dynamics
Fig. 71 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Japan key country dynamics
Fig. 73 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 India key country dynamics
Fig. 75 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Thailand key country dynamics
Fig. 77 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 South Korea key country dynamics
Fig. 79 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Australia key country dynamics
Fig. 81 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Brazil key country dynamics
Fig. 84 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Argentina key country dynamics
Fig. 86 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 South Africa key country dynamics
Fig. 89 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Saudi Arabia key country dynamics
Fig. 91 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 UAE key country dynamics
Fig. 93 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Kuwait key country dynamics
Fig. 95 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Market share of key market players- Continuous Manufacturing for Small Molecule APIs Market

Companies Mentioned

  • Pfizer Inc.
  • GSK plc. (GlaxoSmithKline)
  • Vertex Pharmaceuticals Incorporated
  • Janssen (a subsidiary of Johnson & Johnson)
  • Abbvie Inc.
  • Sterling Pharma Solutions
  • Evonik Industries AG
  • Cambrex Corporation
  • Patheon (part of Thermo Fisher Scientific)
  • Hovione
  • Lonza
  • Phlow
  • Asymchem
  • GEA Group AG
  • Thermo Fisher Scientific
  • Corning Incorporated
  • Coperion GmbH
  • Continuus Pharmaceuticals
  • Chemtrix
  • Vapourtec Ltd
  • Ehrfeld Mikrotechnik GmbH
  • NiTech Solutions Ltd

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedOctober 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 335.6 Million
Forecasted Market Value ( USD ) by 2030 $ 671.52 Million
Compound Annual Growth Rate10.4%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Continuous Manufacturing For Small Molecule APIs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Continuous Manufacturing For Small Molecule APIs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From
Pharmaceutical Continuous Manufacturing Market Report by Therapeutics Type, Formulation, Application, End User, and Region 2024-2032 - Product Image

Pharmaceutical Continuous Manufacturing Market Report by Therapeutics Type, Formulation, Application, End User, and Region 2024-2032

  • Report
  • 141 Pages
  • Global
From
Continuous Manufacturing Market: Distribution by Purpose of Manufacturing, Scale of Operation, Type of Drug Molecule, Type of Continuous Manufacturing Related Service Offered, Type of Dosage Form Offered, Installed Capacity and Geographical Regions, 2022-2035 - Product Image

Continuous Manufacturing Market: Distribution by Purpose of Manufacturing, Scale of Operation, Type of Drug Molecule, Type of Continuous Manufacturing Related Service Offered, Type of Dosage Form Offered, Installed Capacity and Geographical Regions, 2022-2035

  • Report
  • 376 Pages
  • Global
From
Pharmaceutical Continuous Manufacturing Global Market Report 2024 - Product Image

Pharmaceutical Continuous Manufacturing Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Pharmaceutical Continuous Manufacturing Market, Growth Opportunities - Product Image

Pharmaceutical Continuous Manufacturing Market, Growth Opportunities

  • Report
  • 90 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.